GlassScriptPhysician profile
Clarke U Piatt
NPI 1013933217
$9,536.15
in general payments reported to CMS, 2019-2025
51 companies · $2,429 in 2025
The $2,429 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,600 · 2020: $445 · 2021: $395 · 2022: $1,093 · 2023: $1,470 · 2024: $2,105 · 2025: $2,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,919 · Education: $84.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,918.78 |
| Education | $84.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,003.40 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $916.75 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $902.51 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Insmed, INC. | $758.68 | 2019-2025 | Arikayce, Brinsupri |
| Janssen Pharmaceuticals, INC | $579.04 | 2019-2024 | Xarelto |
| Mylan Specialty L.P. | $501.13 | 2019-2024 | Yupelri |
| Inspire Medical Systems, INC. | $459.19 | 2023-2025 | Inspire |
| Genzyme Corporation | $338.29 | 2019-2025 | |
| Harmony Biosciences LLC | $301.95 | 2021-2025 | Wakix |
| Philips North America LLC | $279.31 | 2019-2024 | (Ak6) Vest Therapy |
| Axsome Therapeutics, INC. | $270.88 | 2023-2025 | Sunosi |
| Amgen INC. | $243.62 | 2021-2025 | Tezspire |
| Genentech USA, INC. | $212.61 | 2019-2022 | |
| Abbvie INC. | $198.02 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $174.58 | 2020-2025 | Dupixent |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $171.70 | 2024-2025 | Remede System |
| Pulmonx Corporation | $171.31 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Avadel Cns Pharmaceuticals, LLC | $147.15 | 2023-2025 | Lumryz |
| Optinose US, INC. | $146.69 | 2024-2025 | |
| Grifols USA, LLC | $142.44 | 2021-2025 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $118.24 | 2019 | |
| Electromed, INC. | $118.13 | 2023-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $114.17 | 2020-2025 | Aralast |
| Merck Sharp & Dohme LLC | $110.84 | 2019-2024 | Recarbrio, Zerbaxa |
| United Therapeutics Corporation | $99.71 | 2019-2024 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $91.11 | 2019-2023 | Opsumit, Uptravi |
| Jazz Pharmaceuticals INC. | $90.18 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $82.38 | 2025 | Acthar |
| E.R. Squibb & Sons, L.L.C. | $65.57 | 2022-2024 | Eliquis |
| Vifor Pharma, INC. | $64.39 | 2024-2025 | Zemaira, Veltassa |
| Resmed Corp | $62.48 | 2023-2025 | |
| Mallinckrodt Enterprises LLC | $59.55 | 2019 | |
| Astellas Pharma US INC | $48.92 | 2024 | Cresemba |
| Alexion Pharmaceuticals, INC. | $45.63 | 2021-2024 | Ultomiris |
| Shionogi INC | $45.03 | 2025 | Fetroja |
| Circassia INC. | $43.91 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.34 | 2022-2024 | |
| Abiomed | $38.69 | 2025 | |
| Ani Pharmaceuticals, INC. | $35.65 | 2024 | Purified Cortrophin Gel |
| Phadia US INC. | $27.38 | 2019 | |
| Viatris Specialty LLC | $24.86 | 2025 | Yupelri |
| Pfizer INC. | $24.70 | 2025 | |
| Biomerieux INC | $24.60 | 2023 | |
| Janssen Biotech, INC. | $24.31 | 2024 | Rybrevant |
| Shire North American Group INC | $20.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.31 | 2025 | |
| Baxter Healthcare | $18.66 | 2023 | Hillrom - Life 2000 Ventilation System |
| Lilly USA, LLC | $16.91 | 2019 | |
| Foundation Medicine, INC. | $15.73 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.71 | 2019 | |
| Allergan, INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clarke Piatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.